{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:42:27Z","timestamp":1792716147111,"version":"4.5.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,24]]},"DOI":"10.18632\/oncotarget.5643","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T14:47:41Z","timestamp":1445870861000},"page":"40310-40326","source":"Crossref","is-referenced-by-count":63,"title":["Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion"],"prefix":"10.18632","volume":"6","author":[{"given":"Claire","family":"Henry","sequence":"first","affiliation":[{"name":"Metastasis Research Group, Adult Cancer Program, Lowy Cancer Research Centre and Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Llamosas","sequence":"additional","affiliation":[{"name":"Metastasis Research Group, Adult Cancer Program, Lowy Cancer Research Centre and Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Knipprath-Meszaros","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schoetzau","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Obermann","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Fuenfschilling","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Caduff","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fink","sequence":"additional","affiliation":[{"name":"Department of Gynecology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville","family":"Hacker","sequence":"additional","affiliation":[{"name":"Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Research, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ford","sequence":"additional","affiliation":[{"name":"Metastasis Research Group, Adult Cancer Program, Lowy Cancer Research Centre and Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"The Cancer Genome Atlas","year":"2011","journal-title":"Nature"},{"key":"2","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Haviv","year":"2008","journal-title":"Clin Cancer Res"},{"key":"3","first-page":"983","article-title":"Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer","volume":"5","author":"Konishi","year":"2013","journal-title":"EMBO molecular medicine"},{"key":"4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2407-13-174","article-title":"The Wnt signalling pathway is upregulated in anmodel of acquired tamoxifen resistant breast cancer","volume":"13","author":"Ford","year":"2013","journal-title":"BMC Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ygyno.2014.06.004","article-title":"The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer","volume":"134","author":"Heinzelmann-Schwarz","year":"2014","journal-title":"Gynecologic Oncology"},{"key":"6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/beta-catenin pathway in ovarian cancer: a review","volume":"131","author":"Buchsbaum","year":"2013","journal-title":"Gynecologic Oncology"},{"key":"7","doi-asserted-by":"crossref","first-page":"e54362","DOI":"10.1371\/journal.pone.0054362","article-title":"The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells","volume":"8","author":"Ward","year":"2013","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.25083","article-title":"Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway","volume":"127","author":"Yu","year":"2010","journal-title":"Int J Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ijc.27984","article-title":"The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis","volume":"133","author":"Ward","year":"2013","journal-title":"International Journal of Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00432-014-1824-y","article-title":"Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both beta-catenin dependent and independent Wnt signalling","volume":"141","author":"Ford","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1476-4598-9-170","article-title":"Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer","volume":"9","author":"Fraga","year":"2010","journal-title":"Mol Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"26301","DOI":"10.1074\/jbc.M113.466086","article-title":"Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer","volume":"288","author":"Rathmell","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"13","first-page":"856","article-title":"Up-regulation of ROR2 is associated with unfavorable prognosis and tumor progression in cervical cancer","volume":"8","author":"Jiang","year":"2015","journal-title":"International journal of clinical and experimental pathology"},{"key":"14","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1038\/srep12991","article-title":"High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma","volume":"5","author":"Wang","year":"2015","journal-title":"Scientific reports"},{"key":"15","doi-asserted-by":"publisher","first-page":"24912","DOI":"10.18632\/oncotarget.4701","article-title":"Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"e31127","DOI":"10.1371\/journal.pone.0031127","article-title":"ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth","volume":"7","author":"Kipps","year":"2012","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-12-3832","article-title":"Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis","volume":"73","author":"Kipps","year":"2013","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1038\/srep05811","article-title":"ROR1 expression correlated with poor clinical outcome in human ovarian cancer","volume":"4","author":"Zhu","year":"2014","journal-title":"Scientific reports"},{"key":"19","doi-asserted-by":"crossref","first-page":"17266","DOI":"10.1073\/pnas.1419599111","article-title":"Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy","volume":"111","author":"Kipps","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20","doi-asserted-by":"crossref","first-page":"e31885","DOI":"10.1371\/journal.pone.0031885","article-title":"Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients","volume":"7","author":"Heinzelmann-Schwarz","year":"2012","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"e116101","DOI":"10.1371\/journal.pone.0116101","article-title":"Expression of Ror2 mediates invasive phenotypes in renal cell carcinoma","volume":"9","author":"Janzen","year":"2014","journal-title":"PLoS One"},{"key":"22","doi-asserted-by":"crossref","first-page":"27973","DOI":"10.1074\/jbc.M802325200","article-title":"Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A","volume":"283","author":"Minami","year":"2008","journal-title":"J Biol Chem"},{"key":"23","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1242\/dev.025767","article-title":"Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development","volume":"135","author":"Chen","year":"2008","journal-title":"Development"},{"key":"24","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/MCB.00177-10","article-title":"Ror2\/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization","volume":"30","author":"Minami","year":"2010","journal-title":"Mol Cell Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0712148105","article-title":"Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a","volume":"105","author":"Kipps","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26","doi-asserted-by":"crossref","first-page":"a000141","DOI":"10.1101\/cshperspect.a000141","article-title":"NF-kappaB as a critical link between inflammation and cancer","volume":"1","author":"Karin","year":"2009","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ccr.2012.02.008","article-title":"NKX2-1\/TITF1\/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma","volume":"21","author":"Takahashi","year":"2012","journal-title":"Cancer Cell"},{"key":"28","first-page":"4239","article-title":"Cytoskeleton Network and Cellular Migration Modulated by Nuclear-localized Receptor Tyrosine Kinase ROR1","volume":"31","author":"Lin","year":"2011","journal-title":"Anticancer research"},{"key":"29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2121-11-48","article-title":"Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain","volume":"11","author":"Lin","year":"2010","journal-title":"BMC Cell Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.clml.2015.02.010","article-title":"Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1","volume":"15","author":"Kipps","year":"2015","journal-title":"Clinical lymphoma, myeloma & leukemia"},{"key":"31","doi-asserted-by":"crossref","first-page":"e78339","DOI":"10.1371\/journal.pone.0078339","article-title":"The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells","volume":"8","author":"Mellstedt","year":"2013","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"crossref","first-page":"e59180","DOI":"10.1371\/journal.pone.0059180","article-title":"Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines","volume":"8","author":"Heinzelmann-Schwarz","year":"2013","journal-title":"PloS one"},{"key":"33","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Speleman","year":"2002","journal-title":"Genome Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2144\/000113083","article-title":"TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays","volume":"46","author":"Detmar","year":"2009","journal-title":"BioTechniques"},{"key":"35","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Grambsch","year":"2000"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T16:37:03Z","timestamp":1692117423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":35,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2015,11,24]]}},"alternative-id":["5643","26515598"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5643","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}